Johns Hopkins Transplant Research Center;Vaccination;subvariants;Organ Transplantation;William Werbel;Johns Hopkins Medicine;COVID-19 breakthrough cases;SARS-CoV-2;Immunocompromised;COVID -19
-
Pics News
Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
[ad_1] Newswise — Findings from a two-year study of nearly 2,400 solid organ transplant recipients, conducted by the Johns Hopkins…
Read More »